Enanta Pharmaceuticals Aktie
10,40
EUR
+0,60
EUR
+6,12
%
12,02
USD
+0,52
USD
+4,52
%
Werbung
Enanta Pharmaceuticals Aktie Analyse
| 24.05.19 | Enanta Pharmaceuticals Outperform | Wolfe Research | |
| 21.11.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
| 15.09.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
| 06.04.15 | Enanta Pharmaceuticals Buy | Deutsche Bank AG |
Werbung
Werbung